Common diabetes drug tested for Anti-Aging effects in lung disease
NCT ID NCT07275359
Summary
This early-stage study investigates whether metformin, a medication typically used for diabetes, is safe and well-tolerated in older adults with COPD who do not have diabetes. Researchers will enroll 45 participants to see if metformin changes certain blood markers related to aging. The main goal is to check safety and feasibility, not to cure COPD.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for CHRONIC OBSTRUCTIVE PULMONARY DISEASE (COPD) are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Duke Asthma, Allergy, and Airway Center
Durham, North Carolina, 27705, United States
Contact
Contact Phone: •••-•••-•••• Email: •••••@•••••
Conditions
Explore the condition pages connected to this study.